Media stories about Exponent (NASDAQ:EXPO) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Exponent earned a media sentiment score of 0.00 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.7505781426113 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news articles that may have impacted Accern Sentiment’s rankings:
- Flux Power Lithium 80v 400 AH Battery (aviationpros.com)
- Will Edge & Christian Be At RAW 25th Anniversary Show?, Sheamus On Jason Jordan, WWE Music Power 10 (wrestlinginc.com)
- ALLETE, Inc. (ALE) Clean Energy Announces 40-MW Purchase of Wind Turbines from GE (GE) Renewable Energy (streetinsider.com)
- Allete Inc.: ALLETE Clean Energy Advances Its Growth Strategy with Purchase of Safe Harbor Wind Turbines from GE (twst.com)
- Financial Comparison: Exponent (EXPO) and Lionbridge Technologies (LIOX) (americanbankingnews.com)
Several analysts have issued reports on the stock. Cantor Fitzgerald restated a “buy” rating and issued a $82.00 price target on shares of Exponent in a research report on Sunday, November 5th. SunTrust Banks restated a “hold” rating and issued a $77.00 price target on shares of Exponent in a research report on Thursday, October 19th. BidaskClub lowered shares of Exponent from a “hold” rating to a “sell” rating in a research report on Friday, December 15th. Finally, Zacks Investment Research lowered shares of Exponent from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, December 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. Exponent presently has a consensus rating of “Hold” and an average price target of $80.00.
Shares of Exponent (EXPO) opened at $72.45 on Friday. Exponent has a 12-month low of $55.75 and a 12-month high of $77.15. The firm has a market cap of $1,888.06, a PE ratio of 35.34 and a beta of 0.57.
Exponent (NASDAQ:EXPO) last issued its earnings results on Wednesday, October 18th. The business services provider reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.09. Exponent had a net margin of 16.46% and a return on equity of 17.21%. The business had revenue of $87.60 million for the quarter, compared to analyst estimates of $79.69 million. During the same period in the previous year, the business earned $0.42 EPS. The firm’s revenue was up 12.9% on a year-over-year basis. equities research analysts expect that Exponent will post 2.09 EPS for the current year.
Exponent Company Profile
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.